Work

Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors

Year: 2016

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-016-3074-y

Authors: David C. Smith, John Powderly, James J. Lee, Dale R. Shepard, Johan Wallin, Archana Chaudhary, Grace Yi Chao, Wee Teck Ng, Malcolm I. Mitchell, Gerrit Grau, Raffael Kurek, Patricia LoRusso

Institutions: University of Michigan, Carolina BioOncology Institute, University of Pittsburgh, Cleveland Clinic, Eli Lilly (United States), National University of Singapore, Eli Lilly (Singapore), Eli Lilly (United Kingdom), Eli Lilly (Germany), Yale University

Language: English

Topic: Cardiac electrophysiology and arrhythmias

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W2423170456

FWCI: 0.249

Cites: 20

Cited by: 4

Related to: 10